These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28950392)

  • 21. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.
    Zhong J; Rao X; Rajagopalan S
    Atherosclerosis; 2013 Feb; 226(2):305-14. PubMed ID: 23083681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
    Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
    Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic DPP4 DNA Methylation Associates With Fatty Liver.
    Baumeier C; Saussenthaler S; Kammel A; Jähnert M; Schlüter L; Hesse D; Canouil M; Lobbens S; Caiazzo R; Raverdy V; Pattou F; Nilsson E; Pihlajamäki J; Ling C; Froguel P; Schürmann A; Schwenk RW
    Diabetes; 2017 Jan; 66(1):25-35. PubMed ID: 27999105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
    Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
    Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors.
    Glorie L; D'Haese PC; Verhulst A
    Bone; 2016 Nov; 92():37-49. PubMed ID: 27535784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.
    Nistala R; Savin V
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F661-F670. PubMed ID: 28122713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
    Chae YN; Kim TH; Kim MK; Shin CY; Jung IH; Sohn YS; Son MH
    PLoS One; 2015; 10(12):e0144064. PubMed ID: 26633898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grape seed-derived procyanidins decrease dipeptidyl-peptidase 4 activity and expression.
    González-Abuín N; Martínez-Micaelo N; Blay M; Pujadas G; Garcia-Vallvé S; Pinent M; Ardévol A
    J Agric Food Chem; 2012 Sep; 60(36):9055-61. PubMed ID: 22891874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study.
    Zheng TP; Liu YH; Yang LX; Qin SH; Liu HB
    Atherosclerosis; 2015 Oct; 242(2):580-8. PubMed ID: 26318108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of glucose-dependent insulinotropic polypeptide in adipose tissue inflammation of dipeptidylpeptidase 4-deficient rats.
    Ben-Shlomo S; Zvibel I; Varol C; Spektor L; Shlomai A; Santo EM; Halpern Z; Oren R; Fishman S
    Obesity (Silver Spring); 2013 Nov; 21(11):2331-41. PubMed ID: 23408696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity.
    Böhm A; Wagner R; Machicao F; Holst JJ; Gallwitz B; Stefan N; Fritsche A; Häring HU; Staiger H
    PLoS One; 2017; 12(7):e0181880. PubMed ID: 28750074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Dipeptidyl Peptidase-4, its Substrate Chemokines, and Their Receptors in Adipose Tissue of ob/ob Mice.
    Shin J; Fukuhara A; Onodera T; Yokoyama C; Otsuki M; Shimomura I
    Horm Metab Res; 2017 May; 49(5):380-387. PubMed ID: 28222464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Context-dependent effects of dipeptidyl peptidase 4 inhibitors.
    Jackson EK
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):83-90. PubMed ID: 27898522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
    Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered crosstalk in the dipeptidyl peptidase-4-incretin-immune system in type 1 diabetes: A hypothesis generating pilot study.
    Zóka A; Barna G; Hadarits O; Al-Aissa Z; Wichmann B; Műzes G; Somogyi A; Firneisz G
    Hum Immunol; 2015 Sep; 76(9):667-72. PubMed ID: 26434625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.
    Wang XM; Holz LE; Chowdhury S; Cordoba SP; Evans KA; Gall MG; Vieira de Ribeiro AJ; Zheng YZ; Levy MT; Yu DM; Yao TW; Polak N; Jolly CJ; Bertolino P; McCaughan GW; Gorrell MD
    Immunol Cell Biol; 2017 May; 95(5):443-453. PubMed ID: 27899813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.
    Zheng T; Gao Y; Baskota A; Chen T; Ran X; Tian H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2330-4. PubMed ID: 25029421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
    Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
    Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.